PPARA and steatosis: Indeed, Nrf2, as it is also an antioxidant and anti-inflammatory agent, can suppress hepatic lipogenesis and steatosis and stimulate FA oxidation by improving mitochondrial biogenesis, inhibiting SREBP1, and upregulating PPARα.